Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Attana can today announce that the company has begun a discussion about moving production of consumables, e.g., sensor chips, to the in vitro diagnostics company AroCell AB (Publ).
Attana plans to move production of consumables such as sensor chips and reagents to AroCell. The purpose of the move is to be able to handle increased volumes in order to improve margins. In addition, the move enables better use of both companies' resources and expertise.
Teodor Aastrup, CEO of Attana, comments:
"AroCell's experience and production capacity fit in well with producing Attana's consumables. This increases our flexibility as well as our production margins while freeing up internal resources."
Anders Hultman, CEO of AroCell, comments:
"We look forward to being able to apply our expertise and resources in the production of Attana's consumables. It is also an important step in increasing our revenues and margins in our production unit."